What is Pulmonary Associates?
Pulmonary Associates of Saint Augustine operates as a premier clinical provider specializing in pulmonary care, critical care, and sleep medicine. The practice distinguishes itself through a robust portfolio of diagnostic and therapeutic services targeting chronic conditions such as COPD, asthma, and sleep apnea. By integrating advanced medical technology with a board-certified physician team, the company maintains a strong market position as a leader in respiratory health. Their commitment to patient education and evidence-based medicine ensures that they remain a critical component of the regional healthcare ecosystem, providing essential care in a compassionate, technology-driven environment.
How much funding has Pulmonary Associates raised?
Pulmonary Associates has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Pulmonary Associates
PPP
Public-Private Partnership
What's next for Pulmonary Associates?
The influx of capital is expected to catalyze the next phase of growth for Pulmonary Associates, likely focusing on the modernization of diagnostic facilities and the expansion of their clinical footprint. As the organization transitions through this late-stage development, strategic priorities will likely include the integration of telehealth capabilities and the enhancement of their sleep medicine laboratory infrastructure. By leveraging this investment, the firm aims to optimize patient outcomes while streamlining operational efficiencies, ensuring long-term sustainability in an increasingly competitive healthcare landscape. Future initiatives will likely emphasize the adoption of predictive analytics to improve early intervention for respiratory disorders, further solidifying their reputation as a center of excellence in pulmonary health.
See full Pulmonary Associates company page
